Researchers found that heart failure patients without insurance were less likely to receive evidence-based beta-blockers, implantable cardioverter-defibrillator or anticoagulation for atrial fibrillation compared to patients with private insurance. The Medicaid group was also less likely to receive the beta-blockers or defibrillators, and Medicare patients were less likely to receive certain beta-blockers. All three groups had longer hospital stays than the private insurance group.
Related Articles on Hospital Cardiology:
Oregon’s Salem Hospital, Five Medical Groups Create Heart & Vascular Institute
Oklahoma State University Medical Center Offers Mobile Cardiology Unit
Florida’s Sacred Heart Health System to Form System-Based Cardiology Group
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
